Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vaccine

HPV vaccine prevents cervical cancer cases in deprived groups: study

HPV vaccine reduces cervical cancer cases, particularly in deprived groups, closing health inequalities, according to Cancer Research UK study.

The Hindu

Adolescent girls at risk after receiving Covaxin, says study

Adolescents and those with comorbidities face higher risks of adverse events post-Covaxin vaccination, as per recent study.

The Hindu

Doctor Is Cancer-Free After Using World's First 'Drug Before Surgery' Treatment He Helped Discover

Australian cancer expert fights back and survives aggressive brain tumour with his own experimental treatment, offering hope for future patients.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Doctors group raises concerns over Covishield vaccine side effects

A group of doctors under the banner of Awaken India Movement (AIM) have raised concerns over the side effects of Covishield vaccine in the wake of pharmaceutical giant AstraZeneca admitting in a U.K. court that its vaccine can cause blood clots in rare cases.

The Hindu

C-Section Doubles Risk Of Measles Vaccine Failure; Study Recommends Taking 2 Doses

To have robust protection against measles, children born with C-sections should receive two doses of the vaccination, the study revealed.

Medical Daily

State will offer yellow fever vaccine in three centres

Tamil Nadu Health Department designates centres for yellow fever vaccine administration, with specific hours and payment details provided.

The Hindu

COVID Vaccine May Help Heart Failure Patients Live Longer: Study

Getting vaccinated against COVID-19 can improve the longevity of heart failure patients by 82% compared to those who are unvaccinated.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

50 Wholesome And Hilarious Moments From Veterinary Clinics (New Pics)

Have you ever imagined what a day in the life of a vet might look like? Imagine this: you arrive at work and your first appointment is a cat just waiting for its vaccine. The post 50 Wholesome And Hilarious Moments From Veterinary Clinics (New Pics) first appeared on Bored…

Bored Panda

AstraZeneca’s Covid vaccine is no more – but its remarkable success must not be forgotten

Although dogged by controversy, the firm’s coronavirus jab saved the lives of millions and helped avert humanitarian crises in nations unable to access costly alternatives

The Guardian - UK

Cost of living crisis may be factor in low whooping cough jab rates, experts say

Analysis shows rates of uptake of six-in-one vaccine lowest in the most deprived areas of England

The Guardian - UK

‘The issue is when to pull the trigger’: how prepared are we for human bird flu?

The H5N1 virus has been devastating bird populations, and is now infecting mammals too. Is human-to-human transmission next? And are we ready for another pandemic?

The Guardian - UK

Biotech Rockets 125% On Sanofi Covid Vaccine Agreement

Novavax will receive as much as $1.2 billion as part of a Covid vaccine licensing deal with Sanofi.

Investors Business Daily

Novavax strikes $1.2 billion deal with Sanofi in major turnaround

It's a major turnaround for a drug company that warned last year about its ability to stay in business.

Axios

Moderna Tumbles After The FDA Throws A Curveball On Its Second Product

Moderna stock toppled Friday after the FDA delayed an approval decision on its RSV vaccine until the end of the month.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times

French, US Drug Firms Team Up For Covid-flu Shot

French pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines with a flu shot.

The Hindu

Covishield side effects | Doctors’ group urges Centre to review all COVID vaccines

Doctors express concern over Covishield vaccine safety due to potential blood clot side effects, urging government review and action.

The Hindu

New mRNA vaccine fights brain cancer in children by triggering attack from within

Scientists developed a new messenger-RNA, or mRNA, cancer vaccine, that can deliver treatments more effectively in children who have brain cancer and teach their immune systems to fight back.

LiveScience

New mRNA vaccine for deadly brain cancer triggers a strong immune response

COVID-19 vaccine development paves way to a new class of cancer immunotherapy.

Get all your
news in one place.

100’s of premium titles.
One news app.

Top News

Astrazeneca Withdraws Vaxzevria Vaccine Due To Decline In Demand

AstraZeneca withdraws Vaxzevria vaccine due to decreased demand from newer, more effective mRNA vaccines. Strategic shift in global vaccination landscape.

Evening Standard

AstraZeneca withdraws Covid vaccine worldwide due to 'surplus'

The pharma giant says the decision was made due to the availability of superior vaccines

International Business Times

AstraZeneca Withdraws Covid Vaccine As Demand Dives

Anglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing Covid vaccine Vaxzevria, one of the first produced in the deadly pandemic, citing "commercial reasons" following a slump in demand.

Dynamite News

AstraZeneca withdraws COVID-19 vaccine worldwide, cites commercial reasons

The pharmaceutical giant AstraZeneca's COVID-19 vaccine is being withdrawn worldwide after the company acknowledged for the first time in court documents that it can cause a rare and dangerous side effect, according to a report in the British Newspaper 'The Telegraph'. Read further on Dynamite News:

The Guardian - AU

AstraZeneca withdraws Covid-19 vaccine worldwide, citing surplus of newer vaccines

Pharmaceutical company says newer shots led to decline in demand for AstraZeneca vaccine, which is no longer being manufactured or supplied

The Hindu

TB vaccine MTBVAC gets CDSCO nod for phase II trials

CDSCO approves Bharat Biotech's phase II clinical trial for TB vaccine in India, focusing on safety and immunogenicity.

Investors Business Daily

BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come

BioNTech stock lifted a fraction Monday after Covid vaccine sales dropped again in the first quarter, amid wide losses.

1 … 40 41 42 43

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.